ENO1 and interstitial lung disease: ENO1 as an autoantigen has been reported in systemic sclerosis (SSc)-associated interstitial lung disease [42] and liver fibrosis [43] evidenced as the frequent presence of anti-ENO1 autoantibodies in these patients.